Arthritis gene therapy is becoming a reality

Christopher H Evans, Steven C. Ghivizzani, Paul D. Robbins

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.

Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalNature Reviews Rheumatology
DOIs
StateAccepted/In press - May 9 2018

Fingerprint

Genetic Therapy
Arthritis
Republic of Korea
Osteoarthritis
Genes
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Arthritis gene therapy is becoming a reality. / Evans, Christopher H; Ghivizzani, Steven C.; Robbins, Paul D.

In: Nature Reviews Rheumatology, 09.05.2018, p. 1-2.

Research output: Contribution to journalArticle

Evans, Christopher H ; Ghivizzani, Steven C. ; Robbins, Paul D. / Arthritis gene therapy is becoming a reality. In: Nature Reviews Rheumatology. 2018 ; pp. 1-2.
@article{650383c6c480404e9e4796c130d5d204,
title = "Arthritis gene therapy is becoming a reality",
abstract = "After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.",
author = "Evans, {Christopher H} and Ghivizzani, {Steven C.} and Robbins, {Paul D.}",
year = "2018",
month = "5",
day = "9",
doi = "10.1038/s41584-018-0009-5",
language = "English (US)",
pages = "1--2",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Arthritis gene therapy is becoming a reality

AU - Evans, Christopher H

AU - Ghivizzani, Steven C.

AU - Robbins, Paul D.

PY - 2018/5/9

Y1 - 2018/5/9

N2 - After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.

AB - After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.

UR - http://www.scopus.com/inward/record.url?scp=85046810426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046810426&partnerID=8YFLogxK

U2 - 10.1038/s41584-018-0009-5

DO - 10.1038/s41584-018-0009-5

M3 - Article

C2 - 29743627

AN - SCOPUS:85046810426

SP - 1

EP - 2

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

ER -